Adam Tobias Fox

Adam Tobias Fox

Auto-generated profile, based on publicly available information

Adam Tobias Fox

Department of Paediatric Allergy Evelina London Children's Hospital London UK

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
GTGeorge Du Toit
George Du Toit
YKYitzhak Katz
Yitzhak Katz
PSPeter Sasieni
Peter Sasieni
DMDavid Mesher
David Mesher
SMSoheila J. Maleki
Soheila J. Maleki
GLGideon Lack
Gideon Lack

1 February 2009 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
AFAdam T. Fox
Adam T. Fox
PSPeter Sasieni
Peter Sasieni
GTGeorge du Toit
George du Toit
HSHuma Syed
Huma Syed
GLGideon Lack
Gideon Lack

1 September 2014 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
ASAlexandra F Figueira Santos
Alexandra F Figueira Santos
Abdel DouiriAbdel Douiri
Abdel Douiri
NBNatalia Bécares
Natalia Bécares
SWShih-Ying Wu
Shih-Ying Wu
ASAlick Stephens
Alick Stephens
GLGideon Lack
Gideon Lack
Most of the peanut-sensitized children do not have clinical peanut allergy. In equivocal cases, oral food challenges (OFCs) are required. However, OFCs are laborious and not without risk; thus, a test that could accurately diagnose peanut allergy and reduce the need for OFCs is desirable. To assess the performance of basophil activation test (BAT) as a diagnostic marker for peanut allergy. Peanut-allergic (n = 43), peanut-sensitized but tolerant (n = 36) and non-peanut-sensitized nonallergic (n = 25) children underwent skin prick test (SPT) and specific IgE (sIgE) to peanut and its components. BAT was performed using flow cytometry, and its diagnostic performance was evaluated in relation to allergy versus tolerance to peanut and validated in an independent population (n = 65). BAT in peanut-allergic children showed a peanut dose-dependent upregulation of CD63 and CD203c while there was no significant response to peanut in peanut-sensitized but tolerant (P < .001) and non-peanut-sensitized nonallergic children (P < .001). BAT optimal diagnostic cutoffs showed 97% accuracy, 95% positive predictive value, and 98% negative predictive value. BAT allowed reducing the number of required OFCs by two-thirds. BAT proved particularly useful in cases in which specialists could not accurately diagnose peanut allergy with SPT and sIgE to peanut and to Arah2. Using a 2-step diagnostic approach in which BAT was performed only after equivocal SPT or Arah2-sIgE, BAT had a major effect (97% reduction) on the number of OFCs required. BAT proved to be superior to other diagnostic tests in discriminating between peanut allergy and tolerance, particularly in difficult cases, and reduced the need for OFCs.

1 January 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
GTGeorge Du Toit
George Du Toit
GRGraham Roberts
Graham Roberts
PSPeter H. Sayre
Peter H. Sayre
MPMarshall Plaut
Marshall Plaut
HBHenry T. Bahnson
Henry T. Bahnson
GLGideon Lack
Gideon Lack

23 August 2017 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
CVCarina Venter
Carina Venter
TBTrevor Brown
Trevor Brown
RMRosan Meyer
Rosan Meyer
JWJoanne Walsh
Joanne Walsh
NSNeil Shah
Neil Shah
AFAdam T. Fox
Adam T. Fox
Cow’s milk allergy (CMA) is one of the most common presentations of food allergy seen in early childhood. It is also one of the most complex food allergies, being implicated in IgE-mediated food allergy as well as diverse manifestations of non-IgE-mediated food allergy. For example, gastrointestinal CMA may present as food protein induced enteropathy, enterocolitis or proctocolitis. Concerns regarding the early and timely diagnosis of CMA have been highlighted over the years. In response to these, guideline papers from the United Kingdom (UK), Australia, Europe, the Americas and the World Allergy Organisation have been published. The UK guideline, ‘Diagnosis and management of non-IgE-mediated cow’s milk allergy in infancy—a UK primary care practical guide’ was published in this journal in 2013. This Milk Allergy in Primary Care (MAP) guideline outlines in simple algorithmic form, both the varying presentations of cow’s milk allergy and also focuses on the practical management of the most common presentation, namely mild-to-moderate non-IgE-mediated allergy. Based on the international uptake of the MAP guideline, it became clear that there was a need for practical guidance beyond the UK. Consequently, this paper presents an international interpretation of the MAP guideline to help practitioners in primary care settings around the world. It incorporates further published UK guidance, feedback from UK healthcare professionals and affected families and, importantly, also international guidance and expertise.

1 January 2013 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
CVCarina Venter
Carina Venter
TBTrevor Brown
Trevor Brown
NSNeil Shah
Neil Shah
JWJoanne Walsh
Joanne Walsh
AFAdam T Fox
Adam T Fox
The UK NICE guideline on the Diagnosis and Assessment of Food Allergy in Children and Young People was published in 2011, highlighting the important role of primary care physicians, dietitians, nurses and other community based health care professionals in the diagnosis and assessment of IgE and non‐IgE‐mediated food allergies in children. The guideline suggests that those with suspected IgE‐mediated disease and those suspected to suffer from severe non‐IgE‐mediated disease are referred on to secondary or tertiary level care. What is evident from this guideline is that the responsibility for the diagnostic food challenge, ongoing management and determining of tolerance to cow's milk in children with less severe non‐IgE‐mediated food allergies is ultimately that of the primary care/community based health care staff, but this discussion fell outside of the current NICE guideline. Some clinical members of the guideline development group (CV, JW, ATF, TB) therefore felt that there was a particular need to extend this into a more practical guideline for cow's milk allergy. This subset of the guideline development group with the additional expertise of a paediatric gastroenterologist (NS) therefore aimed to produce a UK Primary Care Guideline for the initial clinical recognition of all forms of cow's milk allergy and the ongoing management of those with non‐severe non‐IgE‐mediated cow's milk allergy in the form of algorithms. These algorithms will be discussed in this review paper, drawing on guidance primarily from the UK NICE guideline, but also from the DRACMA guidelines, ESPGHAN guidelines, Australian guidelines and the US NIAID guidelines.